FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2109450134> ?p ?o ?g. }

• W2109450134 endingPage "1211" @default.
• W2109450134 startingPage "1204" @default.
• W2109450134 abstract "Non-vitamin K antagonist oral anticoagulants (NOACs) are efficacious and safe antithrombotic drugs but the non-availability of an antidote for potential fatal haemorrhagic events is clinically perceived as a strong limitation. We aimed at evaluating the risk of haemorrhage-related fatalities associated with NOACs in patients requiring long-term anticoagulation.MEDLINE, Cochrane Library and Web of Science databases were searched in November 2014 for atrial fibrillation (AF) or venous thromboembolism (VTE) phase III randomised controlled trials (RCT) comparing NOACs with vitamin K antagonists (VKAs) or low molecular weight heparin (LMWH) followed by VKAs. Pooled OR and 95% CIs were estimated through meta-analysis. Heterogeneity was assessed with the I(2) test.Eleven studies were included: 5 on AF and 6 on VTE. A total of 100 324 patients were evaluated in 4 rivaroxaban, 3 dabigatran, 2 apixaban and 2 edoxaban studies. NOAC-treated patients had a 47% odds reduction compared with VKA (OR 0.53; 95% CI 0.42 to 0.68; I(2)=0%; 3 events avoided per 1000 patients) and 64% odds reduction compared with LMWH-VKA (OR 0.36; 95% CI 0.15 to 0.84; I(2)=0%; 1 event avoided per 1000 patients) regarding fatal bleeding risk. Case fatality due to major bleeding was lower in NOAC-treated patients both in AF (OR 0.68; 95% CI 0.48 to 0.96; I(2)=37%; 1 death avoided per 39 major bleedings) and VTE (OR 0.54; 95% CI 0.22 to 1.32; I(2)=0%) patients. AF survivors of major bleeding events treated with NOACs had lower mortality compared with patients treated with VKAs (OR 0.57; 95% CI 0.45 to 0.73; I(2)=0%; 78 events avoided per 1000 survivors to major bleeding).These data suggest that NOACs decrease the risk of fatality cases related to major bleeding events, particularly in AF patients. These results support the safety profile of NOACs even without having a widely available drug-specific antidote." @default.
• W2109450134 created "2016-06-24" @default.
• W2109450134 creator A5015724259 @default.
• W2109450134 creator A5016901394 @default.
• W2109450134 creator A5024180153 @default.
• W2109450134 creator A5034636514 @default.
• W2109450134 creator A5063594200 @default.
• W2109450134 creator A5070535569 @default.
• W2109450134 creator A5082032866 @default.
• W2109450134 creator A5088949299 @default.
• W2109450134 creator A5089640643 @default.
• W2109450134 date "2015-06-02" @default.
• W2109450134 modified "2023-10-15" @default.
• W2109450134 title "Non-vitamin K antagonist oral anticoagulants and major bleeding-related fatality in patients with atrial fibrillation and venous thromboembolism: a systematic review and meta-analysis" @default.
• W2109450134 cites W1981297163 @default.
• W2109450134 cites W2015824469 @default.
• W2109450134 cites W2036740 @default.
• W2109450134 cites W2049852456 @default.
• W2109450134 cites W2052478986 @default.
• W2109450134 cites W2055375232 @default.
• W2109450134 cites W2066676890 @default.
• W2109450134 cites W2079213131 @default.
• W2109450134 cites W2095151586 @default.
• W2109450134 cites W2097854437 @default.
• W2109450134 cites W2117294447 @default.
• W2109450134 cites W2117966469 @default.
• W2109450134 cites W2118092611 @default.
• W2109450134 cites W2126930838 @default.
• W2109450134 cites W2129241155 @default.
• W2109450134 cites W2130199362 @default.
• W2109450134 cites W2134833483 @default.
• W2109450134 cites W2134852288 @default.
• W2109450134 cites W2136489990 @default.
• W2109450134 cites W2139912660 @default.
• W2109450134 cites W2162508946 @default.
• W2109450134 cites W2164586769 @default.
• W2109450134 cites W2166402206 @default.
• W2109450134 cites W2168248028 @default.
• W2109450134 cites W2274799955 @default.
• W2109450134 cites W2320128544 @default.
• W2109450134 cites W2323470162 @default.
• W2109450134 cites W2989714602 @default.
• W2109450134 doi "https://doi.org/10.1136/heartjnl-2015-307489" @default.
• W2109450134 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26037103" @default.
• W2109450134 hasPublicationYear "2015" @default.
• W2109450134 type Work @default.
• W2109450134 sameAs 2109450134 @default.
• W2109450134 citedByCount "102" @default.
• W2109450134 countsByYear W21094501342015 @default.
• W2109450134 countsByYear W21094501342016 @default.
• W2109450134 countsByYear W21094501342017 @default.
• W2109450134 countsByYear W21094501342018 @default.
• W2109450134 countsByYear W21094501342019 @default.
• W2109450134 countsByYear W21094501342020 @default.
• W2109450134 countsByYear W21094501342021 @default.
• W2109450134 countsByYear W21094501342022 @default.
• W2109450134 countsByYear W21094501342023 @default.
• W2109450134 crossrefType "journal-article" @default.
• W2109450134 hasAuthorship W2109450134A5015724259 @default.
• W2109450134 hasAuthorship W2109450134A5016901394 @default.
• W2109450134 hasAuthorship W2109450134A5024180153 @default.
• W2109450134 hasAuthorship W2109450134A5034636514 @default.
• W2109450134 hasAuthorship W2109450134A5063594200 @default.
• W2109450134 hasAuthorship W2109450134A5070535569 @default.
• W2109450134 hasAuthorship W2109450134A5082032866 @default.
• W2109450134 hasAuthorship W2109450134A5088949299 @default.
• W2109450134 hasAuthorship W2109450134A5089640643 @default.
• W2109450134 hasConcept C126322002 @default.
• W2109450134 hasConcept C127413603 @default.
• W2109450134 hasConcept C156957248 @default.
• W2109450134 hasConcept C2776301958 @default.
• W2109450134 hasConcept C2776704044 @default.
• W2109450134 hasConcept C2776884760 @default.
• W2109450134 hasConcept C2777015399 @default.
• W2109450134 hasConcept C2777557582 @default.
• W2109450134 hasConcept C2778661090 @default.
• W2109450134 hasConcept C2778810321 @default.
• W2109450134 hasConcept C2779161974 @default.
• W2109450134 hasConcept C2780290652 @default.
• W2109450134 hasConcept C2780638905 @default.
• W2109450134 hasConcept C2780645631 @default.
• W2109450134 hasConcept C71924100 @default.
• W2109450134 hasConcept C78519656 @default.
• W2109450134 hasConceptScore W2109450134C126322002 @default.
• W2109450134 hasConceptScore W2109450134C127413603 @default.
• W2109450134 hasConceptScore W2109450134C156957248 @default.
• W2109450134 hasConceptScore W2109450134C2776301958 @default.
• W2109450134 hasConceptScore W2109450134C2776704044 @default.
• W2109450134 hasConceptScore W2109450134C2776884760 @default.
• W2109450134 hasConceptScore W2109450134C2777015399 @default.
• W2109450134 hasConceptScore W2109450134C2777557582 @default.
• W2109450134 hasConceptScore W2109450134C2778661090 @default.
• W2109450134 hasConceptScore W2109450134C2778810321 @default.
• W2109450134 hasConceptScore W2109450134C2779161974 @default.
• W2109450134 hasConceptScore W2109450134C2780290652 @default.
• W2109450134 hasConceptScore W2109450134C2780638905 @default.
• W2109450134 hasConceptScore W2109450134C2780645631 @default.
• W2109450134 hasConceptScore W2109450134C71924100 @default.

• next